What is a Dotatate PET scan used for?
What is a PET/CT Ga-68 dotatate scan? This scan is done to diagnose neuroendocrine tumors, which involve both the nervous system and the endocrine glands. For the scan, we will inject a radioactive substance called a tracer into your vein. The tracer used for this scan is called Ga-68 dotatate.
What is gallium Dotatate scan?
A Ga-68 dotatate scan is a test used to check the body for the presence of neuroendocrine tumor cells. You will have this test done in the Nuclear Medicine department. Nuclear medicine is a type of radiology that uses radioactive materials to diagnose or treat diseases.
What is Gallium 68 Dotatate used for?
Gallium Ga 68 dotatate injection is used with a PET scan (positron emission tomography) for localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adults and children. Gallium Ga 68 dotatate is a radiopharmaceutical.
What does a gallium PET scan show?
A gallium scan identifies the cells that are dividing most quickly in your body. It can help detect some cancer cells. It can also help show cells that are rapidly reproducing or responding to an infection somewhere in your body. People with lymphoma (cancer of the lymph system) may need gallium scans.
What does Dotatate stand for?
DOTA-TATE (DOTATATE, DOTA-octreotate, oxodotreotide, DOTA-(Tyr3)-octreotate, and DOTA-0-Tyr3-Octreotate) is an eight amino acid long peptide, with a covalently bonded DOTA bifunctional chelator.
What is DOTATATE therapy?
Lu-DOTATATE therapy is an important treatment option in somatostatin receptor type-2-positive pancreatic, nonpancreatic gastroenteropancreatic-NETs, and lung NETs including metastatic NETs with an unknown primary site and significantly contributed to patients’ OS.
How does a Dotatate scan work?
How does it work? A small amount of a radioactive drug called Dotatate is given by injection before the PET scan. Dotatate attaches to neuroendocrine tumors (NETs) and shows up on the PET image as bright spots.
Is Dotatate a drug?
Lu DOTA-TATE therapy is a form of peptide receptor radionuclide therapy (PRRT) which targets somatostatin receptors (SSR). In that form of application it is a form of targeted drug delivery.